S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
The “Perfect Storm” for Gold (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
[Urgent!] Generational Wealth Gameplan (Ad)
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
The “Perfect Storm” for Gold (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
[Urgent!] Generational Wealth Gameplan (Ad)
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
The “Perfect Storm” for Gold (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
[Urgent!] Generational Wealth Gameplan (Ad)
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
The “Perfect Storm” for Gold (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
[Urgent!] Generational Wealth Gameplan (Ad)
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Free Trial
OTCMKTS:NLBS

NutraLife BioSciences (NLBS) Stock Price, News & Analysis

→ Forget Nvidia, buy this A.I. Stock Now (From InvestorPlace) (Ad)
Free NLBS Stock Alerts
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
$18,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartFinancialsSEC Filings
NLBS stock logo

About NutraLife BioSciences Stock (OTCMKTS:NLBS)

NutraLife BioSciences, Inc., together with its subsidiaries, engages in the development, manufacture, and distribution of nutraceutical, dietary, wellness, and cannabidiol (CBD) products. Its CBD products include cannabinoid-rich hemp oil derived from industrial hemp; tinctures; topical lotions and oils applied directly to the skin to treat pain or inflammation; face creams; massage oils; nutraceutical sprays with CBD as an added ingredient; and pet products. The company also offers other products, such as skincare and sanitizer products. NutraLife BioSciences, Inc. sells its products through nutralifebiosciences.com, as well as through private label distributors, online retailers, and retail outlets. The company was formerly known as NutraFuels, Inc. and changed its name to NutraLife BioSciences, Inc. in March 2019. NutraLife BioSciences, Inc. was incorporated in 2010 and is based in Coconut Creek, Florida.

NLBS Stock News Headlines

April 6, 2023 | finance.yahoo.com
Pressure BioSciences and NutraLife Biosciences Renew Partnership for Development and Distribution of Next Generation Nutraceuticals
February 26, 2023 | benzinga.com
Ensysce Biosciences Stock (NASDAQ:ENSC), Quotes and News Summary
April 17, 2024 | InvestorPlace (Ad)
Forget Nvidia, buy this A.I. Stock Now
Forget Nvidia, Microsoft or Google. Our tech expert and venture capitalist Luke Lango believes this is Elon Musk’s favorite A.I. stock. Why? Because this company is supplying Elon Musk with a key piece of advanced tech for his new A.I. venture.
February 22, 2023 | finance.yahoo.com
MBX Biosciences to Participate in the SVB Securities Global Biopharma Conference
February 18, 2023 | markets.businessinsider.com
Here's what Wall Street expects from Pacific Biosciences of California's earnings
October 27, 2022 | finance.yahoo.com
NutraLife Biosciences Launches a Clinically Tested Focus Stimulant Under a Master Distribution Agreement
September 2, 2022 | usnews.com
Kansas City University of Medicine and Biosciences
August 22, 2022 | finance.yahoo.com
NutraLife BioSciences, Inc. (NLBS)
April 17, 2024 | InvestorPlace (Ad)
Forget Nvidia, buy this A.I. Stock Now
Forget Nvidia, Microsoft or Google. Our tech expert and venture capitalist Luke Lango believes this is Elon Musk’s favorite A.I. stock. Why? Because this company is supplying Elon Musk with a key piece of advanced tech for his new A.I. venture.
July 8, 2022 | finanznachrichten.de
Emergent Health Corp.: Emergent Executes Joint Venture Agreement with Nutralife Biosciences and Provides PharmaZu Corporate Update
July 8, 2022 | apnews.com
Emergent Executes Joint Venture Agreement with Nutralife Biosciences and Provides PharmaZu Corporate Update
July 8, 2022 | finance.yahoo.com
Nutralife Biosciences Executes a Joint Venture Agreement With Emergent Health Corporation for the Co-Production, Co-Marketing, and Distribution of Emergent’s Line of Regenerative, and Other Health-Related Nutraceutical, Skincare and Pet Pro
June 15, 2022 | finance.yahoo.com
NutraLife Biosciences Inc. Engages CFN Media to Reach, Attract Retail, Accredited & Institutional Investors
March 2, 2022 | uk.investing.com
Nutralife Biosciences Inc (NLBS)
February 25, 2022 | benzinga.com
NutraLife Biosciences (OTC: NLBS) Reports Expansion With CRP Partnership Agreement As It Prepares For OTCQB Uplisting
February 7, 2022 | seekingalpha.com
NutraLife Biosciences collaborates with CRP; prepares for OTCQB up-listing
February 6, 2022 | finance.yahoo.com
NutraLife Biosciences Signs Partnership Agreement with CRP & Prepares for OTCQB Uplisting
February 1, 2022 | seekingalpha.com
NutraLife Biosciences announces partnership with Cookies Licensed Retail Products
February 1, 2022 | finance.yahoo.com
NutraLife Biosciences Signs Partnership Agreement with Cookies Licensed Retail Products & Prepares for OTCQB Uplisting
January 27, 2022 | yahoo.com
NutraLife Biosciences, inc. to Webcast Live at VirtualInvestorConferences.com February 3rd
December 19, 2021 | nz.finance.yahoo.com
Omicron: 'The good news is that we have the tools,' doctor says
December 19, 2021 | au.finance.yahoo.com
FeedbackFruits Wins Two Awards at the Reimagine Education Awards
December 17, 2021 | finance.yahoo.com
NutraLife Biosciences Partners with KOR Medical to Create Cannabinoid-Based Wellness Products
July 22, 2021 | sg.finance.yahoo.com
We discussed ousting Johnson, ex-adviser to UK prime minister says
See More Headlines
Receive NLBS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NutraLife BioSciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/17/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Dairy products
Sub-Industry
N/A
Current Symbol
OTCMKTS:NLBS
CUSIP
N/A
CIK
1563463
Web
www.nutralifebiosciences.com
Phone
(888) 509-8901
Fax
954-775-0831
Employees
12
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$630,000.00
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
180,606,000
Free Float
118,189,000
Market Cap
$18,000.00
Optionable
Not Optionable
Beta
-1.01
These 7 Stocks Will Be Magnificent in 2024 Cover
These 7 Stocks Will Be Magnificent in 2024

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Mr. Edgar Ward (Age 52)
    Founder, President, CEO & Director
    Comp: $350k
  • Mr. Nicholas E Ward
    Project & Operations Manager
  • Dr. Kenneth L Duchin Ph.D.
    Chief Clinical Developer
  • Dr. Hongxiang Hui M.D.
    Ph.D., Chief Medical Advisor & Member of Advisory Board

Key Competitors

View All Competitors

NLBS Stock Analysis - Frequently Asked Questions

How do I buy shares of NutraLife BioSciences?

Shares of NLBS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:NLBS) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
The “Perfect Storm” for Gold
Gold Safe Exchange
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
Top 5 Tech Stocks to Buy for 2024
Daily Market Alerts
AI healthcare stock poised for 36,996% growth?
Behind the Markets
Biden out June 13; Kamala won’t replace him?
Paradigm Press
New Trump Bombshell
The Freeport Society
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started
Banyan Hill Publishing